Martin Shkreli Faces New Accusations Over High-Priced Drug
A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.
from NYT > Technology https://ift.tt/38JaGe7
from NYT > Technology https://ift.tt/38JaGe7
Comments
Post a Comment